Literature DB >> 8241859

Cost-benefit analysis.

R Robinson1.   

Abstract

Cost-benefit analysis is probably the most comprehensive method of economic evaluation available and it can be applied in two ways. The human capital approach means that the value of people's contributions is linked to what they are paid. The approach based on individuals' observed or stated preference means that their personal valuations are placed on an activity by assessing how much money they are prepared to accept for an increased risk or to pay for a particular service. Each method has its disadvantages and the most successful that has been devised so far is the "willingness to pay" (stated preference) approach, though the response to this is to a large extent dependent on the income of the person being questioned. There are still problems with its application, however, so its usefulness is limited.

Entities:  

Mesh:

Year:  1993        PMID: 8241859      PMCID: PMC1679054          DOI: 10.1136/bmj.307.6909.924

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  4 in total

Review 1.  Appraising the use of contingent valuation.

Authors:  G C Morrison; M Gyldmark
Journal:  Health Econ       Date:  1992-12       Impact factor: 3.046

Review 2.  Economic evaluation in health care: is there a role for cost-benefit analysis?

Authors:  M Johannesson; B Jönsson
Journal:  Health Policy       Date:  1991-02       Impact factor: 2.980

3.  Willingness to pay and accept risks to cure chronic disease.

Authors:  M S Thompson
Journal:  Am J Public Health       Date:  1986-04       Impact factor: 9.308

4.  Willingness to pay for publicly-provided goods. A possible measure of benefit?

Authors:  C Donaldson
Journal:  J Health Econ       Date:  1990-06       Impact factor: 3.883

  4 in total
  32 in total

Review 1.  Economic evaluation of pharmacy services--fact or fiction?

Authors:  B George; J Silcock
Journal:  Pharm World Sci       Date:  1999-08

Review 2.  Recent advances in the methods of cost-benefit analysis in healthcare. Matching the art to the science.

Authors:  E McIntosh; C Donaldson; M Ryan
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

3.  Health economic evaluation.

Authors:  A Shiell; C Donaldson; C Mitton; G Currie
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

4.  An introduction to economic evaluation.

Authors:  S Goodacre; C McCabe
Journal:  Emerg Med J       Date:  2002-05       Impact factor: 2.740

5.  Being economical with the truth: how to make your idea appear cost effective.

Authors:  S Goodacre; C McCabe
Journal:  Emerg Med J       Date:  2002-07       Impact factor: 2.740

Review 6.  Introduction to health economics for the medical practitioner.

Authors:  D P Kernick
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

7.  Real economics needs to reflect real decisions: a response to Johnson.

Authors:  Mark Sculpher; Karl Claxton
Journal:  Pharmacoeconomics       Date:  2012-02-01       Impact factor: 4.981

8.  The ideal: enemy of the useful?

Authors:  T A Sheldon; A F Long; N Freemantle; F Song
Journal:  Qual Health Care       Date:  1995-03

9.  Economic evaluation in health: a thumb nail sketch.

Authors:  D P Kernick
Journal:  BMJ       Date:  1998-05-30

Review 10.  Is screening for Chlamydia trachomatis infection cost effective?

Authors:  J Paavonen
Journal:  Genitourin Med       Date:  1997-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.